» Articles » PMID: 31308870

A Brief Review of Edema-Adjusted Infarct Volume Measurement Techniques for Rodent Focal Cerebral Ischemia Models with Practical Recommendations

Overview
Date 2019 Jul 17
PMID 31308870
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Determining cerebral infarction volume is an important part of preclinical studies to determine the benefit of potential therapies on stroke outcome. A well-known problem in determining the actual infarction volume of rodent models is the presence of edema. Because of this, algorithms must be utilized to obtain the edema-adjusted ( )-infarct volume. Different methods based on 2,3,5-triphenyltetrazolium hydrochloride (TTC) staining have been published describing algorithms to determine the -infarct volume.

Materials And Methods: Simulated models of infarction and corresponding swelling were employed to determine which absolute method of calculation (Lin et al., Reglodi et al., or Belayev et al.) is the most accurate in calculating the absolute -infarct volume.

Results: The Reglodi and Belayev methods were statistically more accurate in measuring -infarct volume than Lin's method, = 0.0078. Though there was no significant difference between Reglodi's and Belayev's methods for the -infarction volume calculation, Reglodi's approach was closer to the ground-truth infarct volume while also being simpler and more straightforward to use.

Conclusion: We recommend that Reglodi's method, that is -infarct volume = infarct volume × (contralateral hemisphere/ipsilateral hemisphere), to be used in calculating -infarct volume in TTC stained rodent brains. Further, factors such as inhomogeneous infarction distribution in a given brain slice can also contribute to the error in volume calculation. Therefore, the average of the infarct area obtained from anterior and posterior views of a given slice should be used to account for the variation. Considering different factors, we have provided a summary recommendation for calculating the infarction volume.

Citing Articles

Empagliflozin demonstrates neuroprotective and cardioprotective effects by reducing ischemia/reperfusion damage in rat models of ischemic stroke and myocardial infarction.

Dai W, Alavi R, Li J, Carreno J, Pahlevan N, Kloner R Sci Rep. 2025; 15(1):8986.

PMID: 40089564 DOI: 10.1038/s41598-025-93483-7.


Volumetry as a Criterion for Suboccipital Craniectomy after Cerebellar Infarction.

Kapapa T, Pala A, Alber B, Mauer U, Harth A, Neugebauer H J Clin Med. 2024; 13(19).

PMID: 39407749 PMC: 11477441. DOI: 10.3390/jcm13195689.


Therapeutic Effects of Intranasal Administration of Resveratrol on the Rat Model of Brain Ischemia.

Owjfard M, Rahimian Z, Ghaderpanah R, Rafiei E, Sadrian S, Sabaghan M Heliyon. 2024; 10(12):e32592.

PMID: 38952360 PMC: 11215267. DOI: 10.1016/j.heliyon.2024.e32592.


Melatonin at repeated doses alleviates hyperglycemia-exacerbated cerebral ischemia-reperfusion injury at 72 h via anti-inflammation and anti-apoptosis.

Xu Q, Cheung R IBRO Neurosci Rep. 2024; 16:418-427.

PMID: 38500787 PMC: 10945201. DOI: 10.1016/j.ibneur.2024.03.003.


Supplementation with a Symbiotic Induced Neuroprotection and Improved Memory in Rats with Ischemic Stroke.

Cruz-Martinez Y, Aguilar-Ponce L, Romo-Araiza A, Chavez-Guerra A, Martinon S, Ibarra-Garcia A Biomedicines. 2024; 12(1).

PMID: 38255316 PMC: 11326124. DOI: 10.3390/biomedicines12010209.


References
1.
Rodrigues C, Spellman S, Sola S, Grande A, Low W, Steer C . Neuroprotection by a bile acid in an acute stroke model in the rat. J Cereb Blood Flow Metab. 2002; 22(4):463-71. DOI: 10.1097/00004647-200204000-00010. View

2.
Reglodi D, Tamas A, Somogyvari-Vigh A, Szanto Z, Kertes E, Lenard L . Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides. 2003; 23(12):2227-34. DOI: 10.1016/s0196-9781(02)00262-0. View

3.
Yamori Y, Horie R, Handa H, Sato M, Fukase M . Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke. 1976; 7(1):46-53. DOI: 10.1161/01.str.7.1.46. View

4.
Belayev L, Khoutorova L, Deisher T, Belayev A, Busto R, Zhang Y . Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke. 2003; 34(3):758-63. DOI: 10.1161/01.STR.0000056169.45365.15. View

5.
Gerriets T, Stolz E, Walberer M, Muller C, Kluge A, Bachmann A . Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke. 2004; 35(2):566-71. DOI: 10.1161/01.STR.0000113692.38574.57. View